Dr. Robert L Grace, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 207-490-6900 Fax: 207-324-0546 |
Dr. Frederick Ira Rosenberg, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 460 Main Street, Suite 1, Springvale, ME 04083 Phone: 207-324-6182 Fax: 207-324-6182 |
Dr. Jay Morgan Knudsen, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 460 Main Street, Suite 1, Springvale, ME 04083 Phone: 207-324-6182 Fax: 207-324-4336 |
Robert Mcvety Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 460 Main Street, Suite #1, Springvale, ME 04083 Phone: 207-324-6182 |
Dr. Kendra Anne Mendez, DMD Dentist Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 207-490-6900 |
Peter Ver Ploeg Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 207-490-6900 Fax: 207-324-0546 |
Dr. Jacqueline Lee Auger, DMD Dentist Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 207-490-6900 |
Dr. Katelyn Marie Pierson, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 460 Main St Ste 1, Springvale, ME 04083 Phone: 207-324-6182 |
Dr. Ayla Hope Nelson, DMD Dentist Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 690-020-7490 |
Dr. Donald Prescott Warner, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 509 Main Street, Springvale, ME 04083 Phone: 207-324-6080 Fax: 207-490-5593 |
Thomas Guerrette Dentist Medicare: Medicare Enrolled Practice Location: 15 Oak St, Springvale, ME 04083 Phone: 207-490-6900 |
News Archive
Remote Analysis Ltd, a telemedicine services provider, has in cooperation with Elias Pietilä's Qvik Ltd (Wooden Labyrinth, for example) developed an iPhone application for recording and analyzing snoring and sleep apnea. The Sleep Aid –application is now available on the iPhone App Store for € 2,39.
NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months ended March 31, 2010.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Researchers previously showed that overweight and obese individuals with knee osteoarthritis can reduce pain by 50% and significantly improve function and mobility with a 10% or more weight loss over an 18-month period.
› Verified 9 days ago